Abstract
Diseases of endocrine organs and altered secretion of hormones are often associated with characteristic skin lesions. The skin’s ability to react to changes in hormone levels depends on the expression of specific receptors, which fluctuates considerably depending on the skin area. Otherwise, additional factors such as blood circulation, trauma, UV exposure, and the microbiome play an important role. The skin can be the site of pathological changes that occur primarily in an endocrine organ. This is the case with autoimmune diseases, where humoral or cellular immune responses can be directed against both an endocrine organ and the skin. Examples are vitiligo in Addison’s disease or autoimmune thyroiditis. Hormone-secreting tumors of other organs can also be associated with typical skin changes. In addition, the skin is able to produce various hormones such as prolactin, thyroid-stimulating hormone (TSH), thyrotropic hormone (TRH), corticotropin-releasing hormone (CRH), melatonin, melanocyte-stimulating hormones (α-, β-, γ-MSH), adrenocorticotropin (ACTH), and endogenous opioids.
Similar content being viewed by others
References
General Information
Jabbour SA (2003) Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol 4:315–331
Jabbour SA (2010) Skin manifestations of hormone-secreting tumors. Dermatol Ther 23:643–650
Pituitary Gland
Davidovici BB, Orion E, Wolf R (2008) Cutaneous manifestations of pituitary gland diseases. Clin Dermatol 26:288–295
Dos Santos Junior A, Henriques TB, de Mello MP et al (2015) Hyperprolactinemia in children and adolescents with use of risperidone: clinical and molecular genetic aspects. J Child Adolesc Psychopharmacol 25:738–748
Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27:485–534
Kanaka bone C, Kogia C, Abdel Naser MB, Chrousos GP (2016) Skin manifestations of growth hormone-induced diseases. Rev Endocr Metab Disord 17:259–267
Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355:2558–2573
Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I et al (2007) Hypopituitarism. Lancet 369:1461–1470
Spain L, Diem S, Larkin J (2016) Management of toxicities of immune checkpoint inhibitors. Cancer Treat Rev 44:51–60
Tessnow AH, Wilson JD (2011) The changing face of Sheehan’s syndrome. Am J Med Sci 340:402–406
Adrenal Glands
Arlt W, Allolio B (2003) Adrenal insufficiency. Lancet 361:1881–1893
Bertherat J, Groussin L, Bertagna X (2006) Mechanisms of disease: adrenocortical tumors – molecular advances and clinical perspectives. Nat Clin Pract Endocrinol Metab 2:632–641
Chan LF, Clark AJ, Metherell LA (2008) Familial glucocorticoid deficiency: advances in the molecular understanding of ACTH action. Horm Res 69:75–82
Lenders JW, Eisenhofer G, Mannelli M et al (2005) Phaeochromocytoma. Lancet 366:665–675
Newell-Price J, Bertagna X, Grossman AB et al (2006) Cushing’s syndrome. Lancet 367:1605–1617
Nieman LK, Chanco Turner ML (2006) Addison’s disease. Clin Dermatol 24:276–280
Schreuer M, Jansen Y, Planken S, Chevolet I, Kruse V, Neyns B (2017) Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreared patients with advanced BRAF V600 mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial. Lancet Oncol 18:464–472
Sutter JA, Grimberg A (2006) Adrenocortical tumors and hyperplasias in childhood – etiology, genetics, clinical presentation and therapy. Endocr Rev 4:32–39
Gonads
Massart F, Saggese G (2010) Oestrogenic mycotoxin exposures and precocious pubertal development. Int J Androl 33:369–376
Merke DP, Bornstein SR (2005) Congenital adrenal hyperplasia. Lancet 365:2125–2136
Norman RJ, Dewailly D, Legro RS et al (2007) Polycystic ovary syndrome. Lancet 370:685–697
Ranasinghe GC, Piliang MP, Bergfeld WF (2017) Prevalence of hormonal and endocrine dysfunctionin patients with lichen planopilaris (LPP): a retrospective data analysis of 168 patients. J Am Acad Dermatol 76:314–320
Yildiz BO (2006) Diagnosis of hyperandrogenism: clinical criteria. Best Pract Res Clin Endocrinol Metab 20:167–176
Thyroid Gland and Parathyroid Gland
Bodo E, Kany B, Gaspar E et al (2010) Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology 151:1633–1642
Brent GA (2008) Clinical practice. Graves’ disease. N Engl J Med 358:2594–2605
Chaker L, Bianco AC, Jonklaas J, Peeters RP (2017) Hypothyroidism. Lancet 6736:30703
Fuleihan GH, Rubeiz N (2006) Dermatologic manifestations of parathyroid-related disorders. Clin Dermatol 24:281–288
Grüter-Kieslich A (2011) Angeborene Hypothyreose und Struma. In: Michalk D, Schönau M (eds) Differentialdiagnose Pädiatrie, 3rd edn. Elsevier, München, pp S 508–S 513
Spritz RA (2010) Shared genetic relationships underlying generalized Vitiligo and autoimmune thyroid disease. Thyroid 7:745–754
Pancreas
Byun DJ, Wolchock JD, Rosenberg LM, Girotra M (2017) Cancer immunotherapy – immune checkpoint blockade and associated endocrinopathies. Nat Rev Endocrinol 13:195–207
Cavanagh PR, Lipsky BA, Bradbury AW et al (2005) Treatment for diabetic foot ulcers. Lancet 366:1725–1735
Morgan AJ, Schwartz RA (2008) Diabetic dermopathy: a subtle sign with grave implications. J Am Acad Dermatol 58:447–451
Sehgal V, Bhattacharya S, Verma P (2011) Juvenile, insulin-dependent diabetes mellitus, type 1-related dermatoses. J Eur Acad Dermatol Venereol 25:625–636
Polyendocrine Diseases
Bell HK, Poston GJ, Vora J et al (2005) Cutaneous manifestations of the malignant carcinoid syndrome. Br J Dermatol 152:71–75
Betterle C, Dal Pra C, Mantero F et al (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327–364
Lakhani VT, You YN, Wells SA (2007) The multiple endocrine neoplasia syndromes. Annu Rev Med 58:253–265
Michels AW, Gottlieb PA (2010) Autoimmune polyglandular syndromes. Nat Rev Endocrinol 5:270–277
First Describer
Addison T (1849) Chronic suprarenal insufficiency, usually due to tuberculosis of suprarenal capsule. Lond Med Gaz 8:517–518
Allgrove J, Clayden GS, Grant DB (1978) Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 1:1284–1286
Binkley GW (1965) Dermopathy in thediabeticsyndrome. Arch Dermatol 92:625–634
Braun-Falco O, Petzoldt D (1967) E.M.O.-Syndrom. Exophthalmus -Myxoedema circumscriptum praetibiale -Osteoarthropathia hypertrophicans. Münch Med Wochenschr 109:1523–1529
Conn JW (1955) Primary aldosteronism. J Lab Clin Med 45:661–664
Cushing’s H (1932) The pituitary body and its disorders. Lippincott, Philadelphia
Diamond MT (1959) The syndrome of exophthalmos, hypertrophic osteoarthropathy and localized myxedema: a review of the literature and report of a case. Ann Intern Med 50:206–213
Graves RJ (1835) Clinical lectures delivered at the meath hospital during the session 1834–1835. Lecture XII. Newly observed affection of the thyroid. Lond Med Surg 7:515–523
Hashimoto H (1912) Zur Kenntnis der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Arch Klin Chir 97:219–248
Huntley AC (1986) Finger pebbles: a common finding in diabetes mellitus. J Am Acad Dermatol 14:612–617
Krude H, Biebermann H, Luck W et al (1999) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155–157
Marie P (1886) Sur deux cus d’acromégalie. Hypertrophy does not affect the congenital extrénitale of supérieures, inférienres and céphalique. Rev Med 6:297–333
Melin H (1964) An atrophic circumscribed skin lesion in the lower extremities of diabetics. Acta Med Scand 176:1–75
Nelson DH, Meakin JW, Dealy JB Jr et al (1958) ACTH producing tumor of the pituitary gland. N Engl J Med 259:161–164
Schmidt MB (1926) Eine biglanduläre Erkrankung (Nebenniere und Schilddrüse) bei Morbus Addisonii. Verh Dtsch Pathol Ges 21:212–221
Sheehan HL (1937) Postpertum necrosis of anterior pituitary. J Pathol Bacteriol 45:189–214
Simmonds M (1914) Über Hypophysisschwund mit tödlichem Ausgang. Dtsch Med Wochenschr 40:322–323
Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181–191
von Basedow CA (1840) Exophthalmus durch Hypertrophie des Zellgewebes in der Augenhöhle. Wochenschr Ges Heilkd 6:197–204
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Germany, part of Springer Nature
About this entry
Cite this entry
Luger, T., Böhm, M. (2020). Endocrine Diseases. In: Plewig, G., French, L., Ruzicka, T., Kaufmann, R., Hertl, M. (eds) Braun-Falco´s Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-58713-3_98-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-58713-3_98-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-58713-3
Online ISBN: 978-3-662-58713-3
eBook Packages: Springer Reference MedicineReference Module Medicine